Lista de obras - Paul Neeson - Dominio Público Uruguay

A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.

artículo científico publicado en 2006

A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells

artículo científico publicado en 2017

A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma

artículo científico publicado en 2011

A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice

artículo científico publicado en 2014

Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice

artículo científico publicado en 2008

Adoptive immunotherapy: a new era for the treatment of cancer

artículo científico publicado en 2015

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer

artículo científico publicado en 2017

Allogeneic CAR19 cells clear ALL

artículo científico publicado en 2016

Antithyroid and antiadrenal autoantibodies in antiglomerular basement membrane disease, thin basement membrane disease and Alport syndrome

artículo científico publicado en 1998

Are the immuno-stimulatory properties of Lenalidomide extinguished by co-administration of Dexamethasone?

artículo científico publicado en 2012

B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21

artículo científico publicado en 2014

Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue

artículo científico publicado en 2018

Biology and clinical observations of regulatory T cells in cancer immunology

artículo científico publicado en 2011

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

artículo científico publicado en 2021

CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells

artículo científico publicado en 2015

CAR-T cells are serial killers

artículo científico publicado en 2015

CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells

artículo científico publicado en 2014

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

artículo científico publicado en 2017

Characterization of activated lymphocyte-tumor cell adhesion.

artículo científico publicado en 2000

Characterization of the treatment-naive immune microenvironment in melanoma with <i>BRAF</i> mutation

artículo científico publicado en 2022

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

artículo científico publicado en 2018

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor

artículo científico publicado en 2013

Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin

artículo científico publicado en 2000

Detection of anti-phosphatidylethanolamine antibodies using flow cytometry

artículo científico publicado en 1999

Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition

artículo científico publicado en 2016

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.

artículo científico publicado en 2016

ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.

artículo científico publicado en 2000

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

artículo científico publicado en 2013

Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.

artículo científico publicado en 2006

Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression

artículo científico

Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma

artículo científico publicado en 2018

Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype.

artículo científico publicado en 2010

Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data-independent acquisition (DIA) mass spectrometry

artículo científico publicado en 2018

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.

artículo científico publicado en 2010

High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot

scientific article published on 01 June 2020

High mammographic density in women is associated with protumor inflammation

artículo científico publicado en 2018

High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancer

scientific article published on 05 May 2020

Human blood MAIT cell subsets defined using MR1 tetramers.

artículo científico publicado en 2018

IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma

artículo científico publicado en 2018

Immunological battlefield in gastric cancer and role of immunotherapies

artículo científico publicado en 2016

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib

artículo científico publicado en 2015

LMP2 immunoproteasome promotes lymphocyte survival by degrading apoptotic BH3-only proteins

artículo científico publicado en 2018

Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.

artículo científico publicado en 2007

Lymphocyte-facilitated tumour cell adhesion to endothelial cells: the role of high affinity leucocyte integrins

artículo científico publicado en 2003

MAIT cells regulate NK cell-mediated tumor immunity

artículo científico publicado en 2021

Manipulating immune cells for adoptive immunotherapy of cancer

artículo científico

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

artículo científico publicado en 2010

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

artículo científico publicado en 2018

Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss

artículo científico publicado en 2015

Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy

artículo científico publicado en 2014

OMIP-021: Simultaneous quantification of human conventional and innate-like T-cell subsets

artículo científico publicado en 2014

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models

scientific article published on 08 May 2017

Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia

artículo científico publicado en 2013

Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

artículo científico publicado en 2018

Reprogramming the tumor microenvironment to enhance adoptive cellular therapy

artículo científico publicado en 2015

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients.

artículo científico publicado en 2010

The Transcriptional Landscape of Radiation-Treated Human Prostate Cancer: Analysis of a Prospective Tissue Cohort.

artículo científico publicado en 2017

The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells

artículo científico publicado en 2009

The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs.

artículo científico publicado en 2004

The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound

artículo científico publicado en 2014

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

artículo científico publicado en 2010

The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome.

artículo científico publicado en 2010

The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma

artículo científico publicado en 2016

Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment

artículo científico publicado en 2022

Tumor ablation by gene-modified T cells in the absence of autoimmunity.

artículo científico publicado en 2010

Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.

artículo científico publicado en 2004

Lista de obras de Paul Neeson

A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.

A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells

A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma

A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice

Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice

Adoptive immunotherapy: a new era for the treatment of cancer

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer

Allogeneic CAR19 cells clear ALL

Antithyroid and antiadrenal autoantibodies in antiglomerular basement membrane disease, thin basement membrane disease and Alport syndrome

Are the immuno-stimulatory properties of Lenalidomide extinguished by co-administration of Dexamethasone?

B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21

Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue

Biology and clinical observations of regulatory T cells in cancer immunology

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells

CAR-T cells are serial killers

CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Characterization of activated lymphocyte-tumor cell adhesion.

Characterization of the treatment-naive immune microenvironment in melanoma with <i>BRAF</i> mutation

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor

Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin

Detection of anti-phosphatidylethanolamine antibodies using flow cytometry

Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.

ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.

Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression

Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma

Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype.

Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data-independent acquisition (DIA) mass spectrometry

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.

High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot

High mammographic density in women is associated with protumor inflammation

High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancer

Human blood MAIT cell subsets defined using MR1 tetramers.

IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma

Immunological battlefield in gastric cancer and role of immunotherapies

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib

LMP2 immunoproteasome promotes lymphocyte survival by degrading apoptotic BH3-only proteins

Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.

Lymphocyte-facilitated tumour cell adhesion to endothelial cells: the role of high affinity leucocyte integrins

MAIT cells regulate NK cell-mediated tumor immunity

Manipulating immune cells for adoptive immunotherapy of cancer

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss

Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy

OMIP-021: Simultaneous quantification of human conventional and innate-like T-cell subsets

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models

Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia

Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

Reprogramming the tumor microenvironment to enhance adoptive cellular therapy

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients.

The Transcriptional Landscape of Radiation-Treated Human Prostate Cancer: Analysis of a Prospective Tissue Cohort.

The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells

The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs.

The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome.

The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma

Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment

Tumor ablation by gene-modified T cells in the absence of autoimmunity.

Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.